Introduction
The use of gastric segment for bladder reconstruction, was first described by Sinaiko in dogs and later described in humans by Leong, however, this was actually widely accepted for clinical use, after the work presented by Adams in pediatric population. 1 Initially, its main indication is limited to patients with renal failure, metabolic acidosis, or short bowel syndrome. But eventually the process was gaining ground and started using in neurogenic cases for urinary diversion and/or neobladder for bladder cancer, bladder augmentation and management of low capacity bladders secondary to various diseases such as tuberculosis, reconstruction of the urinary tract and bladder extrofias, posterior urethral valves, epispadias among others. 2 Case presentation 49 years male, who comes to the urology department, complaining of 8 months of lower abdominal pain, burning and oppressive type, of variable intensity reaching 9/10, which is occasionally exacerbated by urination, associated with intermittent gross hematuria, dysuria, refers no fever at any time.
Patient with past medical history of bladder and right kidney Tuberculosis (TBC) 25 years ago, treated with a simple right nephrectomy and bladder augmentation with antrum segment of stomach, for low bladder capacity. Never showed any symptom during those 25 years lapsing time.
Hematuria work up is started with renal and urinary tract ultrasound which suggests vegetative lesions vs. intravesical polyps, cystoscopy is performed finding pseudo-diverticulum in right side lateral wall behind left upper neck, and a whitish lesion which is biopsed; no evident tumor lesions. Biopsy showed antrum tissue with mild chronic atrophic gastritis activity, positive for Helicobacter pylori and negative for metaplasia or dysplasia (Fig. 1) . Patient was treated for Heliycobacter Pilory with three medications scheme (Clarithromycin 500 mg/TID, Amoxicillin 1 g/BID, and Omeprazole 40 mg/OD for 10 days) and symptoms were resolved.
Discussion
The use of gastric tissue in the reconstruction of the lower urinary tract has been controversial since its first description in 1950 and its amendment in 1970; gastric tissue is mainly used as an alternative to intestinalcystoplasty (colocystoplasty or ileocystoplasty) in patients with renal insufficiency, in which the metabolic acidosis is a common finding, also in short bowel syndrome, among others.
The stomach produces few mucus and has adequate complacency. Its mucosa is impermeable to most ions, allowing adequate net flow of water. In addition, the mucosa allows easy and effective ureteral reimplantation; reduces rates of urinary tract infection, possibly by aciduria and decreases the frequency of formation of bladder stones. 2 Nevertheless the disadvantages include peptic ulcer in the bladder, perforation of the gastric segment, hyponatremic hypochloremic alkalosis, hypergastrinemia, formation of secondary tumors and maybe more important the hematuria-dysuria syndrome.
Hematuria-dysuria syndrome is characterized by symptoms such as bladder spasms; suprapubic, penis or periurethral pain, coffee brown or macroscopic hematuria without urinary infections; excoriation of the skin, and/or dysuria without infection. 3 Using the Nguyen criteria for the diagnosis of hematuria dysuria syndrome, a wide incidence has been reported; going from 24%, through 36% to 70% in 78, 57 and 23 children study respectively. Usando los criterios de Nguyen, se ha reportado una incidencia amplia del síndrome; desde un 24% en una serie de 78 niños con seguimiento a 8,1 años, llevados a gastrocistoplastia reportada por Plaire, pasando por un 36% en 57 niños tratados entre 1989 y 1992; hasta 70% en un estudio en 23 pacientes con un seguimiento medio de 45 meses.
Although other authors have reported minor incidence as DeFoor in 2003, who reported hematuria-dysuria syndrome in 18% of patients, which were successfully treated in its entirely.
The etiology of the hematuria-dysuria syndrome is not completely known. The decrease in the pH of the urine was not a significant association, although other authors have reported a difference between bladder mucosa and urinary pH. However, patients with irritative urinary symptoms have well responded to histamine receptors 2 blockers, leaving aciduria as the possible etiology of the syndrome. 4 There is no consensus in the management of the hematuria dysuria syndrome, although some studies reported that 13% of cases, the symptoms were reported as mild, self-limiting and did not require additional medical management; 6% patients used histamine 2 receptor blockers to control mild symptoms; 4% were continuously treated with histamine 2 receptor blockers to control symptoms.
While other authors report that up to 70% of patients require of histamine 2 receptor blockers and/or hydrogen bomb inhibitors to control symptoms. 5 Multiple approaches have been studied when managing hematuria dysuria syndrome. Castellan, in 29 patients, showed that the empirical use of high doses antimuscarinics for symptoms of hematuria dysuria syndrome, had no urodynamic or clinical benefit. 6 
Conclusions
The most common complication in gastrocystoplasty is hematuria-dysuria syndrome, symptoms are usually intermittent, self-limiting and improve with time. Most patients are controlled with intermittent use of H2 blockers.
The etiology is believed to be the production of hydrochloric acid by the gastric segment and reduced by the damping effect of urine. However, the symptoms have been seen even with urine acidity in the normal range. An alternative explanation is by Helicobacter pylori, which when treated symptoms are resolved.
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